Antibiotico – resistenza in Campylobacter jejuni /coli in Italia nel corso del 2002: risultati di una indagine policentrica


Submitted: 25 February 2014
Accepted: 25 February 2014
Published: 31 March 2003
Abstract Views: 1270
PDF: 748
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

During 2002, inside Campyg Working Group Project, we examined from 8 italian laboratories the patterns of resistances of 205 strains of Campylobacter spp.These strains were: 88% C. jejuni (68% biotype 1, 31% biotype 2, 1% biotype 3), 11% C. coli (95.5% biotype 1) and 1% Clo’s.We observed these resistances: to erythromycin 3.5% (2.2% in C. jejuni, 13.6% in C. coli), to rokitamicin 2.5 % (1.1% and 13.6% respectively), to ciprofloxacin 49.5% (51.1% and 63.6%), to tetracycline 45.0% (43.3% and 59.1%), to minocycline 41.6% (40.0% and 54.5%), to gentamycin 0.5%, to chloramphenicole no ones. Some differences concerning frequency of resistances were observed among 8 laboratories, also between C. jejuni b. 1 and C. jejuni b. 2, but these were not significative. Some suggests are given for continuing this surveillance, from an epidemiological point of view too.

Crotti, D., D’Annibale, M. L., Spinelli, M., Lanzini, F., Rossi, S., Rossi, C., Bruno, R., Sangiorgio, M. L., & Bucci, M. (2003). Antibiotico – resistenza in Campylobacter jejuni /coli in Italia nel corso del 2002: risultati di una indagine policentrica. Microbiologia Medica, 18(1). https://doi.org/10.4081/mm.2003.3051

Downloads

Download data is not yet available.

Citations